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Abstract. In recent times, there has been an increase in the number of reports for new and rare variants of cutaneous
leishmaniasis (CL). Here, we describe three unusual clinical forms of CL identified in Ecuadorian children. A total of
131 patients with CL were diagnosed over a 2-year period of active search. In 3 (2.29%), the lesions were very unusual;
these included erysipeloid, recidiva cutis (LRC), and disseminated leishmaniasis (DL). The erysipeloid case is charac-
terized by erythematous and indurated plaque seen on the face of a 5-year-old boy; the LRC one is differentiated by
slowly progressing red-brown papules around large scars of healed sores in a 6-year-old girl, and the DL case is
characterized by dozens of cutaneous ulcers distributed in the whole body of a 1-year-old girl. Leishmania parasites were
isolated by lesion aspirate and analyzed by the technique multilocus enzyme electrophoresis (MLEE). All three isolates
were identified as Leishmania (Viannia) panamensis. These distinct clinical variants rarely have been reported previously
in the American cutaneous leishmaniasis, and for the first time L. (V.) panamensis was identified as the etiologic agent.
Our cases extend the spectrum of clinical presentations in New World leishmaniasis.
INTRODUCTION
New World tegumentary leishmaniasis is best known for
the destructive, mutilating lesions of mucocutaneous leishma-
niasis (MCL) or “espundia.” However, cutaneous leishmania-
sis (CL) includes a variety of clinical forms. The most com-
mon clinical form is the “classical” ulcer, which starts as a
nodule, becomes an ulcer with an indurated raised outer bor-
der and sharply incised central crater, and then usually heals
over a period of months. But, some lesions do not ulcerate
and heal but persist as spreading nodules as in diffuse cuta-
neous leishmaniasis (DCL) and in the atypical CL of Central
American countries.1 Another clinical variant, “Uta,” is seen
in the highlands of Peru and Ecuador and is characterized by
small, usually single crusted papules.2,3 Verrucous, Chiclero
ulcer, and sporotrichoid lesions (pian-bois) are also described.
Disseminated cutaneous leishmaniasis (DL) and leishma-
niasis recidiva cutis (LRC) are rare variants. DL is character-
ized by the appearance of multiple pleomorphic lesions in > 2
noncontiguous areas of the body and has been reported ex-
clusively from Brazil4 and a solitary case from French Guiana
and Ecuador.5,6 LRC is characterized by red-brown papules
that appear in or around the scar of a healed sore.7 The
erysipeloid form, which is characterized by erythematous, in-
durated swollen plaques without ulceration, has not been yet
reported in the New World. Other unusual variants are re-
ported, but in the Old World, such as paronychial, chancri-
form, annular, palmo-plantar, erysipeloid, zosteriform, Whit-
low, and sporotrichoid.8–10
Determinants of the clinical presentations of disease are
poorly understood but include factors related to the Leish-
mania species, the host’s immune response, and, possibly, the
saliva of the sandfly vector.11 At least 16 different Leishmania
spp. have been identified as causative agents in the human
New World leishmaniasis falling into both subgenera Leish-
mania and Viannia.12 It is generally accepted that certain spe-
cies predominantly cause major clinical forms; for example,
L. (L.) chagasi for the visceral form and L. (V.) braziliensis
for MCL. However, many of the parasites are capable of
producing in the human host a spectrum of disease rather
than a single clinical form, thus L. (L.) amazonensis is asso-
ciated with CL, MCL, post Kala-azar dermal leishmaniasis,
and the visceral form.13
The usual clinical presentations of leishmaniasis are easily
diagnosed by clinicians in endemic regions, but the unusual
forms may give rise to difficulties in diagnosis and appropriate
treatment. Here, we report three children with atypical vari-
ants of CL acquired in Ecuador, in whom the parasites were
identified as L. (V.) panamensis by multilocus enzyme elec-
trophoresis (MLEE).
MATERIALS AND METHODS
An active search for leishmaniasis was undertaken in the
three natural regions of Ecuador (Pacific coastal, Andean,
and Amazonian) in the period 2001–2003. Diagnosis of leish-
maniasis was confirmed by the demonstration of amastigotes
in slit smears and/or the presence of flagellated promastigotes
in the USMARU medium.14 Parasite strain characterization
was done for 11 different enzyme systems using cellulose ac-
etate electrophoresis enzyme technique. Enzymes include 4
oxido-reductases, 2 isomerases, 4 transferases, and 1 hydro-
lase. Technical conditions for preparation of samples, electro-
phoresis, and staining procedures were followed as described
by Evans.14 For profile comparisons, WHO reference strains
included in this study were as follows: L. amazonensis
(MHOM/BR/73/M2269), L. mexicana (MNYC/BZ/62/M379),
L. braziliensis (MHOM/BR/75/M2904), L. panamensis
(MHOM/PA/71/LS94), and L. guyanensis (MHOM/BR/75/
M4147). We also included L. chagasi (MHOM/BR/74/M2682)
because is reported to be the causative agent of nodular atypi-
cal CL in Central American countries. The genetic relation-
ship among the stocks were established according Sneath and
Sokal.15
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All patients received treatment consisting of parenteral in-
jections of meglumine antimoniate (Glucantime; 20 mg Sb
kg−1 day−1 for 15 days) as is recommended by the Ecuadorian
Ministry of Public Health. The study adhered to the ethical
rules of the Central University of Ecuador in accordance with
Ecuadorian government law.
RESULTS
A total of 131 patients were diagnosed to have CL. Three
of them had atypical disease and are described in this report.
All three came from leishmaniasis-endemic areas of subtropi-
cal Ecuador (humid subtropical forest) at 800–1000 m eleva-
tion. Results of epidemiologic, clinical features, and treat-
ment of the rest of the patients and characterization of their
parasites are reported elsewhere.
Patient 1. A 4-year-old boy presented with a large painless
erythematous lesion on the face (Figure 1). It had evolved
from an initial papule in the left cheeck first noticed 5 months
earlier and which gradually spread. The lesion was treated
FIGURE 1. Clinical image of patient 1, erythematous and indu-
rated plaque in both cheeks joined by a large infiltrate thorough
upper lip and nose. A punch biopsy had been performed 2 weeks ago
at the center of the plaques.
FIGURE 2. A and B. Photographs of patient 2 showing typical
recidivans cutaneous lesion, with several small red-brown papules
(arrows) at the edges of extensive scars where Leishmania parasites
were isolated.
FIGURE 3. Ulcerative lesions disseminated during 3 months on
the head, trunk, legs, and arms in our 1-year-old patient of dissemi-
nated cutaneous leishmaniasis. Note cutaneous lesions in the sole.
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with topical steroids, followed by topical antibiotics and sys-
temic penicillin, but without improvement. On examination,
we found a well-nourished boy, without fever, with a painless,
erythematous and indurated plaque on cheeks, nose, and up-
per lip, but without lesions on the mucous membranes.
Patient 2. A 6-year-old girl presented with a 3-year history
of seven red-brown papules slowly expanding at the periphery
of healed sores on her right and left upper limbs involving
arms, elbows, and forearms. Physical examination of her right
arm showed three extensive atrophic scars of healed sores,
with four small, red-brown papules at their periphery, and on
her left forearm three small red papules in the periphery of
extensive scars. The scars were atrophic, ill-defined, de-
pressed, whitish and pink in color and cosmetically disfiguring
(Figure 2). These cutaneous changes were suspected to be
cutaneous tuberculosis by the local physician. Detailed ques-
tioning revealed that scars represented previous ulcers that
had healed after a year of evolution, without any treatment,
and that after a further year the disease reactivated in the
border of healed lesions and continued spreading at the bor-
ders.
Patient 3. A 1-year-old girl presented with dozens of cuta-
neous ulcers distributed in her head, trunk, arms, and legs
(Figure 3). Past medical history revealed that approximately 4
months earlier, her mother observed a solitary ulcer on the
child’s left thigh. At the same time, the mother and a brother
had similar but localized ulcers. After a week, the patient
developed multiple new skin lesions disseminated over dif-
ferent regions of the body, which persisted. The child suffered
from chronic malnutrition. The local physician diagnosed
chicken pox at first, but later a generalized impetigo, and
prescribed topical and parenteral antibiotics, to which she
showed no response. On physical examination, a total of 69
lesions, either between crusted papules and ulcers, were
counted on all parts of the body even on the palms and soles,
but mucous membranes were not affected.
Diagnosis and identification of Leishmania isolates. Mi-
croscopy showed intracellular Leishmania, and culture
yielded promastigotes. The three isolated stocks were identi-
fied as L. (V.) panamensis by comparing their enzyme profiles
for 11 enzyme systems with the profiles of those of selected
WHO reference strains. The most useful system to differen-
tiate between subgenera and among Viannia species was the
phosphogluconate dehydrogenase (Figure 4), but differences
were also found in the glucose-6-phosphate dehydrogenase
and nucleoside hydrolase. The UPGMA dendrogram built
from the Jaccard’s distance matrix drew the same cluster
(similar isoenzyme profile) between our three stocks and L.
(V.) panamensis reference stock (data not shown). L. chagasi
migrated far from our samples. Treatment resulted in clinical
cure in all three patients.
DISCUSSION
Because of the rarity of the atypical clinical forms of cuta-
neous leishmaniasis reported here, even physicians working
in such an endemic area misdiagnosed them as chicken pox,
erysipelas, and cutaneous tuberculosis and therefore patients
were treated inappropriately. The rarity of these variants in
the current study (2.29%) is corroborated by other surveys
carried out in the country and in other endemic regions in the
New and Old Worlds.1,4,9,10,16 Lesions at unusual sites are
also rarely reported, but several lesions on palms and soles
occurred in our 1-year-old patient.
The differential diagnosis of “classical” ulcers of CL in-
cludes infected insect bites, traumatic ulcers, fungal, myco-
bacterial, and spirochete infections, and squamous cell
carcinoma.17 Disseminated leishmaniasis (DL) should be
differentiated from small pox, paracoccidioidomycosis, and
staphylococcal infection6 and as in our case with chicken pox
and impetigo; in addition, lesions in Brazilian patients re-
sembled leprosy and acne.4 The erysipeloid form on the face
should be distinguished from systemic lupus erythematosus,
cellulitis and erysipelas, rosacea with lymphoedema, and sar-
coidosis. LRC is commonly misdiagnosed as lupus vulgaris,
but blastomycosis, sarcoidosis, and tinea incognita must be
also considered.18
Interestingly and for the first time in the clinical spectrum
of American tegumentary leishmaniasis, L. (V.) panamensis
was identified in all three distinct variants of CL reported
here. Previously, L. (V.) braziliensis in Brazilian patients and
L. (V.) guyanensis in a French Guiana patient were identified
in DL4,5 and L. (L.) amazonensis and L. (V.) braziliensis in
LRC forms.19
WHO20 stated that L. (V.) panamensis cause lesions that
are normally ulcers. However, the current findings and other
reports incriminate this species as the etiological agent for
other clinical forms such as Chiclero ulcers and even for mu-
cosal and for MCL.21 As the clinical pattern of leishmaniasis
is determined by the interaction between the host immune
response and the strain of the parasite implicated,22 the fact
showed in this report that the same parasite cause several
clinical forms suggests that the host immune response is criti-
cal in determining the outcome of L. (V.) panamensis infec-
tion. Indeed, atypical clinical features and locations of Leish-
mania are common in patients co-infected with HIV.23,24
Estimating the importance and complexity of clinical fea-
tures of leishmaniasis and skin diseases in the Tropics, it is
worth reporting unusual and rare clinical forms and localiza-
tions of such diseases. Physicians and researchers need to
appreciate that the local identified species of Leishmania are
capable of causing atypical diseases, and familiarity with the
different clinical presentation of leishmaniasis may facilitate
the diagnosis, and therefore all early treatment may improve
outcome.
FIGURE 4. Comparision of the isoenzyme pattern for 6-phospho-
gluconate deshydrogenase enzyme system of reference strains (WHO
recommended) with our three isolates. Lane 1, L. mexicana. Lane 2,
L. amazonensis. Lane 3, L. chagasi. Lanes 4–6, patients 1–3, respec-
tively. Lane 7, L. panamensis. Lane 8, L. guyanensis. Lane 9, L.
braziliensis.
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